Novartis revenue increased from $48.5 billion in 2016 to $49.1 billion in 2017, a 1.2% increase.
Annual Revenue ($)
Novartis revenue was $49.11 b in FY, 2017 which is a 1.2% year over year increase from the previous period.
Annual Growth Rate (%)
Revenue Breakdown
Business Segment
Geographic Segment
Novartis revenue breakdown by business segment: 67.5% from Innovative Medicines, 20.4% from Sandoz and 12.1% from Alcon
Novartis revenue breakdown by geographic segment: 6.4% from Germany, 36.7% from United States, 6.4% from Japan and 50.5% from Other
| FY, 2017 | FY, 2016 | FY, 2015 | |
|---|---|---|---|
| Innovative Medicines | 33.03 b | 32.56 b | 33.35 b |
| Sandoz | 10.06 b | 10.14 b | 10.07 b |
| Alcon | 6.02 b | 5.81 b | 6 b |
| FY, 2017 | FY, 2016 | FY, 2015 | |
|---|---|---|---|
| Germany | 3.69 b | 3.63 b | 3.16 b |
| United Kingdom | 1.16 b | 1.18 b | 1.28 b |
| France | 2.49 b | 2.39 b | 2.27 b |
| Other | 20.82 b | 20.10 b | 20.59 b |
| United States | 16.94 b | 17.12 b | 18.08 b |
| Switzerland | 836 m | 830 m | 774 m |
| Japan | 3.18 b | 3.27 b | 3.16 b |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.